Evidence map›Paper›PMID 22456378›Full record

ArticlePlastic and reconstructive surgery2012

Amifostine remediates the degenerative effects of radiation on the mineralization capacity of the murine mandible.

Catherine N Tchanque-Fossuo, Alexis Donneys, Sagar S Deshpande, Noah S Nelson, Matt J Boguslawski, K Kelly Gallagher, Deniz Sarhaddi, Behdod Poushanchi, Steven A Goldstein, Steven R Buchman

Abstract read
In one paragraph

Article in Plastic and reconstructive surgery, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Prophylactic administration of Amifostine protects vessel thickness in the setting of irradiated bone.Journal of plastic, reconstructive & aesthetic surgery : JPRAS · 2015
    Article
  7. Therapeutic effects of cytoprotective agent on breast reconstruction after breast cancer surgery.International journal of clinical and experimental medicine · 2015
    Article
  8. Article
  9. Article
  10. Amifostine preserves osteocyte number and osteoid formation in fracture healing following radiotherapy.Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Catherine N Tchanque-FossuoAnn Arbor, Mich. From the University of Michigan Medical School; the University of Michigan; and Orthopedic Surgery, University of Michigan.
Alexis Donneys
Sagar S Deshpande
Noah S Nelson
Matt J Boguslawski
K Kelly Gallagher
Deniz Sarhaddi
Behdod Poushanchi
Steven A Goldstein
Steven R Buchman
Ann Arbor Center for Independent Living · USUniversity of Michigan–Ann Arbor · US

Funding

Translational Optimization of Bone Regeneration in the Irradiated MandibleR01CA125187 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BUCHMAN, STEVEN R · 2007 to 2017
$2.8M
NCI NIH HHS R01 CA125187NCI NIH HHS R01 CA 12587-01
6 · The paper itself

Abstract

backgroundRadiotherapy, a cornerstone of head and neck cancer treatment, causes substantial morbidity to normal adjoining bone. The authors assessed the radioprotective effect of amifostine therapy on the mineralization of the mandible using micro-computed tomography. They hypothesized that amifostine would safeguard the mandible from radiation-induced disruption of the mineralization process and the associated failure of new bone creation.

methodsMale Sprague-Dawley rats were randomized into three groups: control (n = 8), radiation therapy (n = 5), and amifostine (n = 8). Animals in the radiation therapy and amifostine groups underwent human bioequivalent radiation of 70 Gy in five fractions to the left hemimandible. Fifty-six days after irradiation, the hemimandibles were harvested for radiomorphometric analyses.

resultsAmifostine-treated animals exhibited less alopecia, mucositis, and weight loss in addition to increased cortical density in comparison with those treated with radiation therapy. Bone and tissue mineral densities showed statistically significant improvement in amifostine versus radiation therapy, and no difference was observed between amifostine and control groups. Detailed micro-computed tomographic analysis further demonstrated significant differences in the mineralization profile when comparing radiation therapy and amifostine. Amifostine maintained regions of lower mineralization consistent with the preservation of normal remodeling.

conclusionsThe authors have successfully demonstrated the ability of amifostine pretreatment to protect the natural mineralization profile of bone. This reflects the capacity of amifostine prophylaxis to safeguard the normal surrounding mandible from the impediments of collateral damage imposed by irradiation. Further study can correlate these findings with the potential use of amifostine to prevent the devastating associated morbidities of radiotherapy such as pathologic fractures and osteoradionecrosis.

Indexed as

AmifostineAnimalsCalcification, PhysiologicMaleMandibleMicroradiographyRadiation DosageRadiation Injuries, ExperimentalRadiation-Protective AgentsRatsRats, Sprague-DawleyTomography, X-Ray ComputedAmifostineRadiation-Protective Agents

Identifiers

PMID22456378
PMCPMC3315689
OpenAlexW1975898112

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.